Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORAL-28Standard

TURQOZ

ETHINYL ESTRADIOL; NORGESTREL

Standard Dose
0.03MG;0.3MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview TURQOZ is listed in Drugs@FDA under application 202980 (ANDA).

Marketing status: Prescription Active ingredient ETHINYL ESTRADIOL; NORGESTREL Form and strength TABLET;ORAL-28 - 0.03MG;0.3MG Sponsor LUPIN LTD Submission history Latest submission status date: 2023-07-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview TURQOZ is listed in Drugs@FDA under application 202980 (ANDA). Marketing status: Prescription Active ingredient ETHINYL ESTRADIOL; NORGESTREL Form and strength TABLET;ORAL-28 - 0.03MG;0.3MG Sponsor LUPIN LTD Submission history Latest submission status date: 2023-07-31 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.